Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8582 |
High Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD6273 |
Approved |
0.8151 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8085 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.8056 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7905 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7902 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7871 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7725 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7725 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7698 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7639 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7613 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7603 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7589 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD3750 |
Approved |
0.755 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7517 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2309 |
Approved |
0.75 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1281 |
Approved |
0.75 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7451 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7448 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7431 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7415 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7413 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7413 |
Intermediate Similarity |
NPD3267 |
Approved |
0.741 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.74 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7381 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD920 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7357 |
Intermediate Similarity |
NPD17 |
Approved |
0.7357 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7355 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7234 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7202 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD6353 |
Approved |
0.719 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7162 |
Intermediate Similarity |
NPD411 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7134 |
Intermediate Similarity |
NPD919 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7092 |
Intermediate Similarity |
NPD9545 |
Approved |
0.709 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7044 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7042 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD37 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD1933 |
Approved |
0.702 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7014 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD6800 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4870 |
Approved |
0.6994 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD8313 |
Approved |
0.6994 |
Remote Similarity |
NPD8312 |
Approved |
0.6993 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD5494 |
Approved |
0.6982 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6677 |
Suspended |
0.6974 |
Remote Similarity |
NPD1607 |
Approved |
0.697 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD2897 |
Discontinued |
0.6966 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD9494 |
Approved |
0.6957 |
Remote Similarity |
NPD2651 |
Approved |
0.6957 |
Remote Similarity |
NPD2649 |
Approved |
0.6954 |
Remote Similarity |
NPD3140 |
Approved |
0.6954 |
Remote Similarity |
NPD1240 |
Approved |
0.6954 |
Remote Similarity |
NPD3142 |
Approved |
0.6951 |
Remote Similarity |
NPD2296 |
Approved |
0.6951 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.695 |
Remote Similarity |
NPD9493 |
Approved |
0.6946 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6944 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6939 |
Remote Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD1470 |
Approved |
0.6937 |
Remote Similarity |
NPD5403 |
Approved |
0.6937
|
Remote Similarity |
NPD3873 |
Phase 3 |